Tag: cannabinoids

Plants without the plant? A look at cannabinoids made with yeasts instead of plants

Plants without the plant? A look at cannabinoids made with yeasts instead of plants

September 6, 2020 |

We’ve covered beef without the cow, pork without the pig, but what about plants without the plant? That’s what BioMediCan is tackling – technically they aren’t creating a plant without a plant, but they are creating a plant compound, cannabinoids, without cannabis plants, skipping the growing, the sunlight, the watering, the harvesting, and all those […]

Read More

Cannabinoid, meet biochem – Lygos acquires Librede to scale up and commercialize cannabinoid production

Cannabinoid, meet biochem – Lygos acquires Librede to scale up and commercialize cannabinoid production

January 18, 2020 |

While Cheech and Chong now say that marijuana’s coolness is gone, cannabinoids on the other hand are taking off like crazy and Lygos is pushing the gas pedal to the max to scale up and commercialize cannabinoids. In California comes the hot news that Lygos, who you may know for their sugar converting advanced biotech […]

Read More

Amyris ships first fermentation derived cannabinoid to LAVVAN

Amyris ships first fermentation derived cannabinoid to LAVVAN

December 29, 2019 |

In California, Amyris successfully shipped the first cannabinoid to its partner, LAVVAN. These ingredients are produced with Amyris’s fermentation technology platform which allows Amyris to scale ingredients that are rarer within the cannabis plant, and difficult and extremely expensive to extract in quantity. Amyris is also well on its way to the shipment of a […]

Read More

Amyris seals $255 million development and commercialization deal for cannabinoids

Amyris seals $255 million development and commercialization deal for cannabinoids

February 6, 2019 |

In California, Amyris announced that it has signed a binding term sheet for a planned cannabinoid development, licensing and commercialization partnership valued at up to $255 million (not including significant royalties once the products are commercialized) with a confidential partner. The $255 million in payments include an upfront payment and the remainder are linked to milestones […]

Read More